Merck
CN

Rat atrial responses to Bothrops jararacussu (jararacuçu) snake venom.

Toxicology (2014-06-29)
Mariana A P Rodrigues, Lourdes Dias, André L Rennó, Norma C Sousa, Adriana Smaal, Delano A da Silva, Stephen Hyslop
摘要

Envenoming by the pitviper Bothrops jararacussu produces cardiovascular alterations, including coagulopathy, systemic hemorrhage, hypotension, circulatory shock and renal failure. In this work, we examined the activity of this venom in rat isolated right atria. Incubation with venom (0.025, 0.05, 0.1 and 0.2mg/ml) caused concentration-dependent muscle contracture that was not reversed by washing. Muscle damage was seen histologically and confirmed by quantification of creatine kinase-MB (CK-MB) release. Heating and preincubation of venom with p-bromophenacyl bromide (a phospholipase A2 inhibitor) abolished the venom-induced contracture and muscle damage. In contrast, indomethacin, a non-selective inhibitor of cyclooxygenase, and verapamil, a voltage-gated Ca(2+) channel blocker, did not affect the responses to venom. Preincubation of venom with Bothrops or Bothrops/Crotalus antivenom or the addition of antivenom soon after venom attenuated the venom-induced changes in atrial function and tissue damage. These results indicate that B. jararacussu venom adversely affected rat atrial contractile activity and muscle organization through the action of venom PLA2; these venom-induced alterations were attenuated by antivenom.

材料
货号
品牌
产品描述

Sigma-Aldrich
吲哚美辛, 98.5-100.5% (in accordance with EP)
Sigma-Aldrich
(±)-维拉帕米 盐酸盐, ≥99% (titration), powder
Sigma-Aldrich
肌酸磷酸激酶 来源于兔肌肉, Type I, salt-free, lyophilized powder, ≥150 units/mg protein
Supelco
吲哚美辛, Pharmaceutical Secondary Standard; Certified Reference Material
USP
维拉帕米 盐酸盐, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
2,4′-二溴苯乙酮, >98%
Sigma-Aldrich
肌酸磷酸激酶 来源于牛心脏, Type III, salt-free, lyophilized powder, ≥30 units/mg protein
Supelco
(±)-维拉帕米 盐酸盐, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
吲哚美辛, meets USP testing specifications
维拉帕米, European Pharmacopoeia (EP) Reference Standard
Supelco
2,4′-二溴苯乙酮, for HPLC derivatization, LiChropur, ≥99.0% (HPLC)
Supelco
Verapamil hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
吲哚美辛, European Pharmacopoeia (EP) Reference Standard
USP
吲哚美辛, United States Pharmacopeia (USP) Reference Standard